ArticleAME case reports2026
Challenging the known: unusual case report of acromegaly and subclinical Cushing's disease combination.
Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pituitary neuroendocrine tumors (PitNETs) are usually characterized by hormone secretion profiles that correspond to lineage-specific transcription factor expression. Growth hormone (GH) and prolactin (PRL) secretion is regulated by pituitary-specific transcription factor-1 (Pit-1), whereas adrenocorticotropic hormone (ACTH) production is classically dependent on T-box transcription factor 19 (T-pit). Accordingly, the concomitant secretion of GH and ACTH from a single pituitary adenoma is exceedingly rare. Case Description: A 41-year-old man presented with typical acromegalic features and severe metabolic abnormalities, including poorly controlled diabetes mellitus, but without overt clinical manifestations of Cushing's syndrome. Endocrine evaluation demonstrated markedly elevated GH and insulin-like growth factor-1 levels, failure of GH suppression during oral glucose tolerance testing, and biochemical evidence of ACTH-dependent hypercortisolism, consistent with subclinical Cushing's disease. Pituitary magnetic resonance imaging revealed an invasive macroadenoma extending into the sphenoid sinus. The patient underwent transsphenoidal resection of the tumor. Histopathological examination showed diffuse and strong immunoreactivity for GH and PRL, with focal and sparse ACTH positivity. Immunohistochemistry revealed robust Pit-1 expression, while T-pit staining was entirely negative, indicating a mammosomatotroph PitNET with aberrant ACTH expression rather than true corticotroph lineage differentiation. Postoperatively, ACTH and cortisol levels declined substantially, cortisol suppressibility was restored, and hypothalamic-pituitary-adrenal axis function remained intact, confirming remission of hypercortisolism. In contrast, biochemical remission of acromegaly was incomplete, requiring continued follow-up. Conclusions: This case describes a rare Pit-1 lineage pituitary macroadenoma associated with acromegaly and subclinical Cushing's disease. The discordance between ACTH hypersecretion and absent T-pit expression highlights atypical hormone regulation in plurihormonal PitNETs and underscores the limitations of current lineage-based classifications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.